Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Soligenix, Inc. - Common Stock (NQ:SNGX)

1.580 -0.020 (-1.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Soligenix, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Nasdaq Down 50 Points; ConocoPhillips Posts Upbeat Earnings
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Thursday. The Dow traded down 1.19% to 33,015.85 while the NASDAQ fell 0.49% to 11,966.96. The S&P... 
Via Benzinga
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44. 
Via Benzinga
Why Are Soligenix Shares Trading Higher Today
 
Via Benzinga
FDA Asks For Additional Successful Trial To Approve Soligenix's Rare Cancer Candidate
 
Via Benzinga
Why Are Soligenix Shares Plummeting Today?
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Soligenix (NASDAQ: SNGX) Reports Strong Clinical Results from Compatibility Study of HyBryte as a Treatment for Cutaneous T-Cell Lymphoma
Soligenix, Inc. (NASDAQ: SNGX) is engaged as a late-stage biopharmaceutical company that is focused on the research, development and commercialization 
Via Spotlight Growth
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 127 companies set new 52-week lows. 
Via Benzinga
This Combination Therapy Could Help Change Cancer Treatment — Benzinga Looks Deeper Into Allarity Therapeutics' Trial, Including An Interview With An Oncology Expert
Allarity Therapeutics (NASDAQ: ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drug 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 65 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 114 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 56 companies made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 135 companies reached new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 74 companies achieved new lows for the year. 
Via Benzinga
Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Death
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 79 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Nasdaq Turns Higher; Soligenix Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.16% to 34,191.46 while the NASDAQ rose 0.51% to 11,952.38. The... 
Via Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users. 
Via Benzinga
Crude Oil Down 1%; SkyWater Technology Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday. The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P... 
Via Benzinga
OXY Stock Alert: Occidental Petroleum Receives Goldman Sachs Upgrade
Occidental Petroleum (OXY) stock is on the rise Tuesday following an bullish upgrade and new price target from Goldman Sachs. 
Via InvestorPlace
Why Is Soligenix (SNGX) Stock Down 35% Today?
Soligenix (SNGX) stock is falling hard on Tuesday with heavy trading after the company's HyBryte cancer drug was rejected by the FDA. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday, 40 stocks hit new 52-week lows. 
Via Benzinga
Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42%... 
Via Benzinga
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
  During Friday, 48 stocks hit new 52-week lows. 
Via Benzinga
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.